AU1143899A - Transdermal delivery of 3,4-diarylchromans - Google Patents
Transdermal delivery of 3,4-diarylchromansInfo
- Publication number
- AU1143899A AU1143899A AU11438/99A AU1143899A AU1143899A AU 1143899 A AU1143899 A AU 1143899A AU 11438/99 A AU11438/99 A AU 11438/99A AU 1143899 A AU1143899 A AU 1143899A AU 1143899 A AU1143899 A AU 1143899A
- Authority
- AU
- Australia
- Prior art keywords
- diarylchromans
- transdermal delivery
- transdermal
- delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK127897 | 1997-11-10 | ||
DK1278/97 | 1997-11-10 | ||
PCT/DK1998/000481 WO1999024032A1 (en) | 1997-11-10 | 1998-11-09 | Transdermal delivery of 3,4-diarylchromans |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1143899A true AU1143899A (en) | 1999-05-31 |
Family
ID=8103049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11438/99A Abandoned AU1143899A (en) | 1997-11-10 | 1998-11-09 | Transdermal delivery of 3,4-diarylchromans |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1028724A1 (en) |
AU (1) | AU1143899A (en) |
WO (1) | WO1999024032A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU770573B2 (en) * | 1998-07-09 | 2004-02-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI982733A (en) * | 1998-12-17 | 2000-06-18 | Orion Yhtymae Oyj | Soluble compositions of triphenylethylene estrogens |
AU779027B2 (en) * | 1999-07-27 | 2005-01-06 | Hisamitsu Pharmaceutical Co., Inc. | Patches for external use |
GB0003310D0 (en) * | 2000-02-15 | 2000-04-05 | Univ Sheffield | Bone formation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5451603A (en) * | 1993-03-11 | 1995-09-19 | Zymogenetics, Inc. | 3,4-diarylchromans for treatment of dermatitis |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
TW448046B (en) * | 1995-01-20 | 2001-08-01 | Novo Nordisk As | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity |
BR9706966A (en) * | 1996-01-11 | 1999-05-04 | Novo Nordisk As | Use of the 1-enanciomer of a compound and process for treatment or prophylaxis of breast cancer |
-
1998
- 1998-11-09 AU AU11438/99A patent/AU1143899A/en not_active Abandoned
- 1998-11-09 WO PCT/DK1998/000481 patent/WO1999024032A1/en not_active Application Discontinuation
- 1998-11-09 EP EP98954240A patent/EP1028724A1/en not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU770573B2 (en) * | 1998-07-09 | 2004-02-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
Also Published As
Publication number | Publication date |
---|---|
EP1028724A1 (en) | 2000-08-23 |
WO1999024032A1 (en) | 1999-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7077098A (en) | Transdermal delivery system | |
AU6740298A (en) | Pharmaceutical composition | |
AU7908098A (en) | Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones | |
AU5387898A (en) | Pharmaceutical agents | |
AU8495998A (en) | Improved dosage units | |
AU7333398A (en) | Nasal melatonin composition | |
AU9343098A (en) | Pharmaceutical composition | |
AU8695298A (en) | Compounds and uses thereof | |
AU7761498A (en) | Algicides | |
AU1143899A (en) | Transdermal delivery of 3,4-diarylchromans | |
AU5944898A (en) | Catheter | |
AU6525998A (en) | Improved metallo-endopeptidases | |
AU5490298A (en) | Syringe | |
AU1171099A (en) | Therapeutic agents | |
AU5093199A (en) | Transdermal delivery system | |
AU1046799A (en) | Compound, composition and use | |
AUPP003297A0 (en) | 4,5-diaryloxazole compounds | |
AU7641098A (en) | Therapeutic composition | |
AU6965398A (en) | Preparation of thiazoles using 1,3-dihalopropenes | |
AU8693198A (en) | Compounds and uses thereof | |
AU6958898A (en) | Preparation of heterocycles using 1,3-dihalopropenes | |
AU9229598A (en) | Transplacental delivery of oligonucleotides | |
AU1046299A (en) | Compound, composition and use | |
AU1046399A (en) | Compound, composition and use | |
AU1046499A (en) | Compound, composition and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |